Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 01-1997 | |
| Sales | 99,832 | 95,627 | 101,319 | 76,240 | 59,653 |
| Cost of Goods | 94,670 | 88,861 | 98,395 | 73,655 | 58,243 |
| Gross Profit | 5,162 | 6,766 | 2,925 | 2,586 | 1,410 |
| Operating Expenses | 2,569 | 2,831 | 1,560 | 629 | 371 |
| Operating Income | 2,592 | 3,936 | 1,365 | 1,957 | 1,039 |
| Other Income | -42 | 1,726 | -7,214 | 699 | -223 |
| Pre-tax Income | 2,550 | 5,662 | -5,849 | 2,655 | 816 |
| Income Tax | 1,146 | 1,105 | 780 | 908 | -445 |
| Net Income Continuous | 1,404 | 4,557 | -6,629 | 1,747 | 1,261 |
| Net Income Discontinuous | 884 | -483 | N/A | N/A | 5,639 |
| Minority Interests | N/A | N/A | 130 | N/A | N/A |
| Net Income | $2,288 | $4,074 | $-6,629 | $1,747 | $6,900 |
| EPS Basic Total Ops | 0.21 | 0.41 | -0.69 | 0.23 | 1.03 |
| EPS Basic Continuous Ops | 0.13 | 0.45 | -0.69 | 0.23 | 0.19 |
| EPS Basic Discontinuous Ops | 0.08 | -0.04 | 0.00 | 0.00 | 0.85 |
| EPS Diluted Total Ops | 0.21 | 0.37 | -0.69 | 0.23 | 1.03 |
| EPS Diluted Continuous Ops | 0.13 | 0.41 | -0.69 | 0.23 | 0.19 |
| EPS Diluted Discontinuous Ops | 0.07 | -0.04 | 0.00 | 0.00 | 0.85 |
| EBITDA(a) | $5,162 | $6,766 | $2,925 | $2,586 | $1,410 |